National Mutual Insurance Federation of Agricultural Cooperatives held its position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,700 shares of the pharmacy operator’s stock at the end of the 2nd quarter. National Mutual Insurance Federation of Agricultural Cooperatives’ holdings in CVS Health Corporation were worth $1,746,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. TB Alternative Assets Ltd. bought a new position in shares of CVS Health Corporation during the second quarter worth about $121,000. Gemmer Asset Management LLC raised its position in shares of CVS Health Corporation by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. SRS Capital Advisors Inc. raised its position in shares of CVS Health Corporation by 48.2% during the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after acquiring an additional 734 shares during the last quarter. Grace & White Inc. NY bought a new position in shares of CVS Health Corporation during the second quarter worth about $199,000. Finally, Nadler Financial Group Inc. bought a new position in shares of CVS Health Corporation during the second quarter worth about $202,000. Hedge funds and other institutional investors own 82.04% of the company’s stock.
A number of equities analysts have recently issued reports on CVS shares. Robert W. Baird restated a “hold” rating and set a $77.00 price objective on shares of CVS Health Corporation in a research report on Friday, October 27th. Mizuho set a $90.00 target price on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, October 24th. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Loop Capital assumed coverage on CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price for the company. Finally, Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a report on Sunday, September 10th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $85.82.
CVS Health Corporation (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The business’s revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.64 earnings per share. equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.87%. CVS Health Corporation’s payout ratio is 41.32%.
In related news, insider Larry J. Merlo sold 241,150 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the sale, the insider now directly owns 299,255 shares in the company, valued at approximately $24,859,112.85. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the sale, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is currently owned by corporate insiders.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.